| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 535 | 5.446 | 14.941 | 30.388 | 44.235 | - |
| Total Income - EUR | - | - | - | - | 535 | 5.446 | 14.942 | 30.388 | 44.235 | - |
| Total Expenses - EUR | - | - | - | - | 1.504 | 5.188 | 9.824 | 20.180 | 32.186 | - |
| Gross Profit/Loss - EUR | - | - | - | - | -969 | 258 | 5.118 | 10.209 | 12.049 | - |
| Net Profit/Loss - EUR | - | - | - | - | -985 | 96 | 4.678 | 9.700 | 11.673 | - |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Transerv Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.596 | 1.338 | 2.747 | 3.666 | 3.074 | - |
| Current Assets | - | - | - | - | 318 | 3.120 | 3.514 | 17.739 | 25.808 | - |
| Inventories | - | - | - | - | 0 | 0 | 1.461 | 2.743 | 2.867 | - |
| Receivables | - | - | - | - | 0 | 765 | 1.475 | 5.505 | 7.998 | - |
| Cash | - | - | - | - | 318 | 2.355 | 578 | 9.491 | 14.943 | - |
| Shareholders Funds | - | - | - | - | -943 | -829 | 3.868 | 13.581 | 25.213 | - |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | - | 2.858 | 5.286 | 2.393 | 7.824 | 3.669 | - |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3313 - 3313" | |||||||||
| CAEN Financial Year |
3313
|
|||||||||
Comments - Transerv Medical S.r.l.